Previous Close | 0.0497 |
Open | 0.0495 |
Bid | 0.0490 x N/A |
Ask | 0.0650 x N/A |
Day's Range | 0.0495 - 0.0496 |
52 Week Range | 0.0315 - 0.5160 |
Volume | |
Avg. Volume | 3,045 |
Market Cap | 3.54M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
TEL AVIV, Israel, May 04, 2022--ironSource (NYSE: IS), a leading business platform for the App Economy, today announced the launch of Luna Views, allowing customers using ironSource Luna app marketing software to easily and quickly access critical campaign breakdowns that would normally require resource-intensive manual work of a BI team. Based on live data, Luna Views offers a library of ready-made widgets covering popular metrics and activities like creative testing, best and worst performing
The Commission issued its Reasons for Decision in the above named matter.
Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, is pleased to announce that Mr. David L. Tousley, CPA, MBA, has been appointed as a new independent director to replace William Garner, M.D., who stepped down from the Tryp Board of Directors in connection with his investment in the Company's previously announced non-brokered private placement (the "Private Placem